- India's trial by fire
- 38 trial deaths in India in 2 years but SAE reporting overkill skewing data
- Foreign firms deny trials caused deaths in India amid concerns over reporting norms
- Pharma's negative image a real challenge, says Novartis India chief
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.